Ontology highlight
ABSTRACT: Introduction
The water-soluble mangosteen pericarp extract's (WME) effect was investigated in Alzheimer's disease (AD).Methods
The participants received 4 mg/kg/day of WME for 24 weeks (low dose, n = 33), 4 mg/kg/day for 12 weeks and then 8 mg/kg/day for 12 weeks (high dose, n = 33); or a placebo (n = 42). The outcomes were neuropsychiatric test scores, safety, tolerability, and the blood 4-hydroxynonenal level.Results
The proportion of participants who achieved the minimum clinically important difference for the Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog; -2.6 points) at 24 weeks was significantly higher in the low-dose group (and a trend in the high-dose group) than in the placebo group. WME appeared safe and well tolerated. At 24 weeks, the
SUBMITTER: Muangpaisan W
PROVIDER: S-EPMC8984095 | biostudies-literature | 2022
REPOSITORIES: biostudies-literature